Benzodiazepine Use in Older Adults: Safety Concerns with Xanax 0.375mg
Alprazolam (Xanax) at 0.375mg is not recommended for a 63-year-old patient due to increased risks of adverse effects including cognitive impairment, delirium, falls, and fractures. 1
Risks of Benzodiazepines in Older Adults
The American Geriatrics Society's 2019 Beers Criteria strongly recommends against using benzodiazepines in older adults (65 years and older) due to:
- Increased sensitivity to benzodiazepine effects in older adults
- Decreased metabolism of long-acting agents
- Higher risk of cognitive impairment
- Increased risk of delirium
- Elevated fall and fracture risk 1
This recommendation is supported by moderate-quality evidence and carries a strong recommendation strength, indicating that the harms clearly outweigh the benefits.
Specific Concerns with Alprazolam in Older Adults
While the FDA label for alprazolam indicates that it can be used in elderly patients, it specifically recommends:
- Starting at a much lower dose (0.25mg, 2-3 times daily)
- Gradual dose increases only if needed and tolerated
- Recognition that elderly patients may be especially sensitive to benzodiazepine effects 2
Alternative Approaches
For older adults requiring treatment for anxiety or insomnia:
Non-pharmacological interventions:
- Cognitive behavioral therapy
- Relaxation techniques
- Sleep hygiene education 3
If medication is absolutely necessary:
- Consider safer alternatives like SSRIs or SNRIs for anxiety
- Use the lowest possible dose for the shortest duration
- Implement close monitoring for adverse effects 3
Special Considerations for Benzodiazepine Use
If a benzodiazepine is deemed absolutely necessary despite the risks:
- The American Academy of Sleep Medicine notes that benzodiazepines should not be used as first-line treatment for agitation unless behavioral interventions have failed 1
- Enhanced Recovery After Surgery (ERAS) guidelines specifically advise against benzodiazepine pre-medication in older adults 1
- Long-term use is associated with reduced mobility, decreased functional independence, and increased risk of falls and fractures 3
Conclusion
Given the patient's age of 63 years, the 0.375mg dose of alprazolam carries significant risks that outweigh potential benefits. The American Geriatrics Society's strong recommendation against benzodiazepine use in older adults should guide clinical decision-making in this case. If treatment for anxiety or insomnia is needed, safer non-pharmacological approaches should be prioritized, with consideration of alternative pharmacological options only if absolutely necessary.